BSX vs HNNAZ · P/E 20, rev $20.07B vs rev $35.5M
Boston Scientific Corp (BSX) versus Hennessy Advisors Inc. 4.875% Notes due 2026 (HNNAZ) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Hennessy Advisors Inc. 4.875% Notes due 2026 (HNNAZ) common stock listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported HNNAZ revenue for 2025-09-30 was $35.5M. Net income was $10.0M. Revenue was up 19.9% from 2024-09-30 to 2025-09-30. HNNAZ currently screens at market cap $0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HNNAZ currently screens at market cap $0.
Not investment advice. Open the BSX and HNNAZ stock pages for the full models.
Not investment advice.